Sector ratings Charles River Laboratories International, Inc. Berne S.E.

Stocks

End-of-day quote Berne S.E. Other stock markets 2026-07-24			5-day change	1st Jan Change
186.14 ^CHF	+0.96%		+2.54%	-

07-20	Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix…
07-13	BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LONZA GROUP AG	46.86B		AAA
REVOLUTION MEDICINES, INC.	40.23B	-	B	-	-
BEONE MEDICINES AG	36.23B		-
IQVIA HOLDINGS INC.	34.72B		AAA
CELLTRION, INC.	27.89B		A
MEDPACE HOLDINGS, INC.	16.79B		BBB
ASCENDIS PHARMA A/S	16.74B	-	-	-	-
EUROFINS SCIENTIFIC SE	13.12B		AA
ICON PUBLIC LIMITED COMPANY	12.7B		AAA
BIO-TECHNE CORPORATION	11.16B		AA
ABIVAX	11.07B	-	BBB	-	-
APOGEE THERAPEUTICS, INC.	10.08B	-	B	-	-
PHARMARON BEIJING CO., LTD.	9.49B		AA
IONIS PHARMACEUTICALS, INC.	9.35B	-	A	-	-
KYMERA THERAPEUTICS, INC.	9.1B	-	BBB	-	-
PRAXIS PRECISION MEDICINES, INC.	9.07B	-	B	-	-
ALKERMES PLC	8.82B		A
PROTAGONIST THERAPEUTICS, INC.	8.75B		BB		-
QIAGEN N.V.	8.56B		AAA
Average	17.93B		A
Weighted average by Cap.			A